Edit
Melinta Therapeutics
https://melinta.com/melinta-therapeutics-announces-strategic-realignment-and-new-corporate-identity-based-on-strong-scientific-foundation-of-rib-x-pharmaceuticals/Last activity: 20.09.2022
High touch and big impact are trademarks of Melinta. We are nimble and agile without sacrificing our dedication to adding value everywhere we go.
You see, the people of Melinta are believers. Woven into the fiber of our culture is tenacity, brilliance, resilience, excellence and courage. Nothing can weaken our resolve. We take each responsibility seriously, because when we make a move, it matters.
Watch us as we grow. We are the company of the moment and the enterprise of the future. We’re unparalleled in our ability to meet the unmet needs of our patients, and we do so collaboratively. Because we believe the most diverse teams produce the most meaningful impact.
We can’t wait to make legendary strides. Every step counts.
Location: United States, New Jersey, Morristown
Employees: 201-500
Phone: +1 203-624-5606
Total raised: $137M
Founded date: 2000
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 10.06.2015 | - | $67M | - |
| 10.02.2014 | - | $70M | - |
Mentions in press and media 14
| Date | Title | Description | Source |
| 20.09.2022 | Menarini and SciClone Sign Exclusive Licensing Agreement to ... | Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising pre... | en.prnasia... |
| 20.09.2021 | Melinta Therapeutics : Announces Two Key Milestones Expandin... | Melinta Therapeutics (Melinta), a commercial-stage company providing innovative therapies for acute ... | marketscre... |
| 15.03.2021 | Melinta Therapeutics Announces FDA Approval of KIMYRSA™ (ori... | MORRISTOWN, N.J.--(BUSINESS WIRE)--Mar 15, 2021-- Melinta Therapeutics, LLC (Melinta), a commercial-... | oaoa.com/n... |
| 04.08.2020 | Could Drug-Resistant Bacteria Cause The Next Pandemic? | Venetians dressed as plague doctors pose during Carnival in their city's Piazza San Marco on ... [+]... | forbes.com... |
| 18.03.2020 | Saving lives should be good business. Why doesn’t that apply... | I have spent my career as a biomedical entrepreneur working to develop products that have the potent... | statnews.c... |
| 07.01.2020 | Antibiotics need a special place in the drug pricing debate | Melinta Therapeutics, one of the few companies to recently bring a new antibiotic to market, filed f... | statnews.c... |
| 20.06.2019 | In starved antibiotic field, Melinta soars as FDA grants... | Such is the state of affairs in antibiotic land that the FDA agreeing to priority review an... | endpts.com... |
| 21.05.2019 | New antibiotics are urgently needed, but economics stand in ... | Achaogen’s journey from promise to penury illustrates the Herculean task the biopharma industry face... | medcitynew... |
| 10.12.2018 | What’s holding pharma back from the next antibiotic breakthr... | In the five years since the alarm sounded about so-called superbugs, the world has continued to grap... | statnews.c... |
| 10.06.2015 | Melinta Therapeutics Closes $67M in Funding | Melinta Therapeutics, a New Haven, Connecticut-based antibiotics developer, closed $67m in funding. ... | finsmes.co... |
Show more